Clinical Trials in Nashville

Showing 20181-20200 of 20,298 trials

Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs

NCT00006397

The purpose of this study is to see how safe and effective it is to give multi-drug treatment with indinavir (IDV) plus ritonavir (RTV) plus enteric-coated didanosine (ddI) plus stavudine (d4T) and if there are differences in responses between men and women.

HIV Infections

PPD Development, LP200 participantsStarted Aug 2000

Berkeley, California, United States • Los Angeles, California, United States • Los Angeles, California, United States +12 more locations

UNKNOWNPhase 3< 1 mile

Vaccine Therapy for Patients With Stage IV Melanoma

NCT00052156

This is a Phase III study in patients with melanoma that has spread to the lymph nodes and/or a distant organ, and who have had all of their cancer surgically removed. The purpose of this study is to evaluate the ability of the CancerVax™ vaccine to prevent or slow the recurrence of melanoma.

Malignant Melanoma

CancerVax Corporation670 participants

Tucson, Arizona, United States • Little Rock, Arkansas, United States • Little Rock, Arkansas, United States +74 more locations

Differences Between Women and Men Taking a Combination of Indinavir, Ritonavir, Enteric-Coated Didanosine, and Stavudine Who Previously Took Anti-HIV Drugs

Vaccine Therapy for Patients With Stage IV Melanoma

Find Trials by Condition in Nashville

Safety and Efficacy of Sitaxsentan in the Treatment of Pulmonary Arterial Hypertension

Agitation in Alzheimer's Disease

African-American Heart Failure Trial

Randomized Study of Decreased Hyperinsulinemia on the Ovulatory Response to Clomiphene Citrate in Women With Polycystic Ovary Syndrome

An Open Label Evaluation of the Safety and Pharmacokinetics of Ganciclovir in Children

Randomized Study of Oral Contraceptives or Hormone Replacement Therapy in Women With Systemic Lupus Erythematosus

A Phase I Trial To Evaluate the Safety and Immunogenicity of the UBI HIV-1MN PND Peptide Immunogen, Given by IM Injection, in Combination With the UBI Microparticulate Monovalent HIV-1 MN Branched Peptide Given Orally, in HIV-1 Uninfected Volunteers.

Combination Treatment Using Capravirine (AG1549), Nelfinavir, and Two Nucleoside Reverse Transcriptase Inhibitors in HIV Patients Who Failed Initial Combination Therapy

Safety Study for Treatment of Wet Macular Degeneration Using the TheraSight(TM) Ocular Brachytherapy System

A Study of the Safety and Efficacy of Chronically Administered MDL 28,574A in the Treatment of HIV-Infected Patients

A Study of Efavirenz in HIV-Infected Patients Who Have Never Taken Anti-HIV Drugs

Noninvasive Prenatal Diagnosis: Using Fetal Cells From Maternal Blood

A Phase I Study of the Safety and Pharmacokinetics of Recombinant CD4 (rCD4) in Infants and Children Infected With or at Risk for HIV Infection

A Safety Study to Evaluate 12 Weeks of Treatment with Clevudine in Patients Infected with Hepatitis B Virus.

A Study of Spiramycin in the Treatment of Patients With AIDS-Related Diarrhea

Lidorestat (IDD 676) for the Treatment of Diabetic Neuropathy

A Phase I Pharmacokinetic Study in HIV-Positive Subjects of Oral Ganciclovir and Concomitant Antiretroviral Zidovudine and Didanosine

Study of 111In-DAC as an Medical Imaging Agent for Lung Cancer and Brain Cancer Consistent With Metastatic Lung Cancer